
India's Cadila Healthcare is aiming to triple monthly production of a Covid-19 vaccine candidate, ZyCoV-D, to as many as 30 million doses, its managing director said on Monday, as the country battles a massive wave of infections.
May 24, 2021 at 02:37PM
0 Comments